MoonLake Immunotherapeuti... (MLTX)

40.60

0.89 (2.24%)

At close: Mar 04, 2025, 3:30 PM

MoonLake Immunotherapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-121.24B	-44.08M	-64.51M	-53.64M	-90.84K
Depreciation & Amortization	1.38B	13.16K	12.36K	4.97K	n/a
Stock-Based Compensation	7.28B	7.11M	9.65K	10.86K	n/a
Other Working Capital	-2M	-6.22M	-44.8K	3.06M	-215.94K
Other Non-Cash Items	-4.01B	399.51K	372.49K	12.57M	-9.92K
Deferred Income Tax	n/a	n/a	n/a	1.4M	n/a
Change in Working Capital	n/a	-6.22M	-1.43M	4.48M	-215.94K
Operating Cash Flow	-116.59B	-42.78M	-55.89M	-35.18M	-316.69K
Capital Expenditures	-519.52K	-284.63K	-16.01K	-50.71K	n/a
Acquisitions	n/a	n/a	32.32K	n/a	n/a
Purchase of Investments	-350.28B	-175.73M	-42.23M	n/a	-115M
Sales Maturities Of Investments	145.2B	150.83M	9.9M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-32.32K	n/a	n/a
Investing Cash Flow	-205.6B	-25.18M	-32.34M	-50.71K	-115M
Debt Repayment	n/a	n/a	-15M	15M	n/a
Common Stock Repurchased	n/a	n/a	n/a	-6.2K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	51.26B	-2.75M	134.69M	n/a	-347.38K
Financial Cash Flow	51.31B	479.7M	119.69M	43.26M	116.65M
Net Cash Flow	-270.74B	411.66M	31.47M	6.7M	1.34M
Free Cash Flow	-117.11B	-43.06M	-55.91M	-35.23M	-316.69K